Schmidt, Ralf http://orcid.org/0000-0002-6697-0363
Ward, Carl C. http://orcid.org/0000-0002-1188-4839
Dajani, Rama http://orcid.org/0000-0002-8479-8800
Armour-Garb, Zev
Ota, Mineto http://orcid.org/0000-0003-4552-8573
Allain, Vincent
Hernandez, Rosmely
Layeghi, Madeline
Xing, Galen
Goudy, Laine
Dorovskyi, Dmytro
Wang, Charlotte
Chen, Yan Yi
Ye, Chun Jimmie
Shy, Brian R. http://orcid.org/0000-0001-9569-3708
Gilbert, Luke A. http://orcid.org/0000-0001-5854-0825
Eyquem, Justin http://orcid.org/0000-0001-8262-1190
Pritchard, Jonathan K. http://orcid.org/0000-0002-8828-5236
Dodgson, Stacie E. http://orcid.org/0000-0002-6622-5507
Marson, Alexander http://orcid.org/0000-0002-2734-5776
Article History
Received: 12 May 2023
Accepted: 3 November 2023
First Online: 13 December 2023
Competing interests
: A.M. is a co-founder of Function Bio, Arsenal Biosciences, Spotlight Therapeutics and Survey Genomics, serves on the boards of directors at Function Bio, Spotlight Therapeutics and Survey Genomics, was a board observer at Arsenal Biosciences, is a member of the scientific advisory boards of Function Bio, Arsenal Biosciences, Spotlight Therapeutics, Survey Genomics, NewLimit, Amgen, Tenaya, and Lightcast owns stock in Arsenal Biosciences, Spotlight Therapeutics, NewLimit, Survey Genomics, PACT Pharma, Tenaya, and Lightcast, and has received fees from Arsenal Biosciences, Spotlight Therapeutics, NewLimit, 23andMe, PACT Pharma, Juno Therapeutics, Tenaya, Lightcast, Trizell, Vertex, Merck, Amgen, Genentech, AlphaSights, Clearview Healthcare, Rupert Case Management, Bernstein, GLG, Survey Genomics, and ALDA. A.M. is an investor in and informal advisor to Offline Ventures and a client of EPIQ. C.W., S.E.D., R.S. and A.M. are shareholders of Function Bio. The Marson laboratory has received research support from Juno Therapeutics, Epinomics, Sanofi, GlaxoSmithKline, Gilead, and Anthem. J.E. is a compensated co-founder at Mnemo Therapeutics. J.E. owns stocks in Mnemo Therapeutics and Cytovia Therapeutics. J.E. is a compensated scientific advisor for Enterome, Treefrog Therapeutics and Resolution Therapeutics. The Eyquem lab has received research support from Cytovia Therapeutic, Mnemo Therapeutics and Takeda. J.E. is a holder of patents pertaining to but not resulting from this work. L.A.G. has filed patents on CRISPR approaches and is a co-founder of Chroma Medicine. R.S., C.W. and A.M. are listed as inventors on patent applications related to this work. The other authors declare no competing interests.